Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiveness overseer NICE.

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Shares undercut their 200-day line and ... the tax charge Eli Lilly disclosed on Oct. 8. Though Mounjaro and Zepbound lagged forecasts, revenue from another notable type 2 diabetes treatment ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

The Chairman and Managing Director of Eli Lilly ... of Eli Lilly and Co., India, disclosed on January 3rd, during the announcement of a price cut in the company's human insulin product 'Huminsulin ...

Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes ... approved in the US for first-line treatment of mantle cell lymphoma.

Huminsulin is used for adult and pediatric patient with Type 1 and Type 2 diabetes mellitus that aids in regulation of blood glucose.